N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.

N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.

AIM: To determine the mechanism of weight loss caused by high doses of N-butyldeoxynojirimycin (NB-DNJ) in healthy lean and leptin-deficient obese (ob/ob) mice. METHODS: Healthy lean and obese mice were treated with NB-DNJ by the following methods: admixed with their diet, delivered by subcutaneous...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Priestman, D, van der Spoel, A, Butters, T, Dwek, R, Platt, F
Format:	Journal article
Język:	English
Wydane:	2008

Podobne zapisy

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
od: Walden, C, i wsp.
Wydane: (2006)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
od: Andersson, U, i wsp.
Wydane: (2000)

Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.
od: Heare, T, i wsp.
Wydane: (2007)

NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
od: Jeyakumar, M, i wsp.
Wydane: (2004)

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
od: Fischer, P, i wsp.
Wydane: (1995)

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.
od: Cox, T, i wsp.
Wydane: (2000)

Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.
od: Elstein, D, i wsp.
Wydane: (2004)

Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
od: Denny, C, i wsp.
Wydane: (2010)

N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery.
od: Pollock, S, i wsp.
Wydane: (2008)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
od: Ranes, M, i wsp.
Wydane: (2001)

Imino sugar therapy for type 1 Gaucher disease.
od: Priestman, D, i wsp.
Wydane: (2000)

Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception.
od: van der Spoel, A, i wsp.
Wydane: (2002)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
od: van der Spoel, A, i wsp.
Wydane: (2002)

Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
od: Walden, C, i wsp.
Wydane: (2007)

The Next Generation of Obesity Treatments: Beyond Suppressing Appetite
od: Nicole M Avena, i wsp.
Wydane: (2013-10-01)

Sarcoidosis presenting as a loss of weight with preserved appetite
od: Asitha Goonetilleke, i wsp.
Wydane: (2023-08-01)

Appetite, reward and obesity: the causes and consequences of eating behaviors
od: Tanya eZilberter
Wydane: (2015-04-01)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
od: Priestman, D, i wsp.
Wydane: (2008)

Food, eating and obesity : the psychobiological basis of appetite and weight control /
od: 419112 Mela, David J., i wsp.
Wydane: (1998)

Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy
od: Altabas V, i wsp.
Wydane: (2015-07-01)

N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV
od: Lauren C. Boudewyn, i wsp.
Wydane: (2017-09-01)

Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells: application to glycoprotein crystallization.
od: Butters, T, i wsp.
Wydane: (1999)

Altered motivation masks appetitive learning potential of obese mice
od: Mazen R. Harb, i wsp.
Wydane: (2014-10-01)

Effects of biscuit fortified with whey protein isolate and wheat bran on weight loss, energy intake, appetite score, and appetite regulating hormones among overweight or obese adults
od: Zahra Hassanzadeh-Rostami, i wsp.
Wydane: (2020-07-01)

The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials
od: Ranil Jayawardena, i wsp.
Wydane: (2021-11-01)

Alkylated imino sugars, reversible male infertility-inducing agents, do not change the genetic integrity of male mouse germ cells, despite severe deformities of spermatozoal structures.
od: Suganuma, R, i wsp.
Wydane: (2004)

Alkylated imino sugars, reversible male infertility-inducing agents, do not affect the genetic integrity of male mouse germ cells during short-term treatment despite induction of sperm deformities.
od: Suganuma, R, i wsp.
Wydane: (2005)

Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression
od: Yajun Wang, i wsp.
Wydane: (2021-04-01)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.
od: Garner, B, i wsp.
Wydane: (2002)

Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
od: Branza-Nichita, N, i wsp.
Wydane: (2001)

Editorial: Appetite Control in Obesity
od: Alessio Molfino, i wsp.
Wydane: (2022-06-01)

Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin.
od: Pelled, D, i wsp.
Wydane: (2003)

Radiological Findings of a 62-Year-Old Male with Loss of Weight and Appetite
od: Matthew Ng MMed (FM), FCFPS
Wydane: (2011-06-01)

Does an acute bout of high intensity interval exercise suppress appetite in obese women?
od: Sepideh Khalaj, i wsp.
Wydane: (2020-08-01)

Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.
od: Simpson, M, i wsp.
Wydane: (2004)

Sleep, appetite, and obesity--what is the link?
od: Patricia Prinz
Wydane: (2004-12-01)

Pre- and post- prandial appetite hormone levels in normal weight and severely obese women
od: Wiebke Gail, i wsp.
Wydane: (2009-08-01)

Child with loss of appetite and dietary vomiting
od: Simon Barreault, i wsp.
Wydane: (2020-10-01)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
od: Butters, T, i wsp.
Wydane: (2005)

Therapeutic applications of imino sugars in lysosomal storage disorders.
od: Butters, T, i wsp.
Wydane: (2003)